Could a Pillow-Like device quiet sleep apnea without drugs?
NCT ID NCT07492420
First seen Jun 27, 2026 · Last updated Sep 16, 2026 · Updated 2 times
Summary
This study tests the MedCline Sleep System, a device placed on the bed to keep people sleeping on their side. It aims to reduce breathing pauses and snoring in adults with mild obstructive sleep apnea. Researchers will measure changes in apnea and oxygen levels during sleep. The trial involves 35 participants and is currently recruiting.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MedCline Sleep System (positional therapy device)
- What this could lead to
- If it works, this device could offer a simple, drug-free way to manage mild sleep apnea at home.
- What could go wrong
- This is a small early study with only 35 participants. The device may not work for everyone, and results may not apply to more severe cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
Aug 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosis with mild obstructive sleep apnea (AHI 5-14.9) 2. PSG or HST performed within last 24 months 3. Individuals aged 18 or older 4. Must routinely sleep on a standard mattress and must be able to accommodate the width of the MedCline Sleep System (30") 5. Must be in overall good health, with no significant medical conditions that would interfere with the study procedures or the ability to sleep safely using the MedCline Sleep System 6. Ability to provide written informed consent in accordance with IRB principles 7. Must be stable on any medications for at least 3 months prior to the date of consent Exclusion Criteria: 1. Diagnosis of moderate to severe OSA (AHI \>15) or central sleep apnea 2. Has undergone surgical procedures for sleep apnea within the last six months 3. Clinically significant cardiac or respiratory conditions that may interfere with the study intervention or outcomes. 4. Chronic pain or musculoskeletal disorders, e.g., spinal deformities, scoliosis, kyphosis, back injuries, spinal compressions, or injuries that may affect their ability to sleep comfortably in a lateral position 5. Pregnant or planning to become pregnant during study period 6. Any conditions or circumstances that require frequent night-time awakenings (e.g., nocturia, caregiving responsibilities, or other health issues) 7. Unable or unwilling to use the MedCline Sleep System as required by the study protocol 8. Currently using substances or medications known to significantly alter sleep architecture or respiratory function (e.g., sedatives, narcotics, or alcohol dependency)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mild obstructive sleep apnea are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clayton Sleep Institute
St Louis, Missouri, 63123, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.